Adaptimmune Therapeutics plc (Nasdaq:ADAP) announced on 8/14/18 a favorable review of safety data from the second dose cohort of patients who received one billion transduced SPEAR T‑cells... read more
Adaptimmune Therapeutics plc (Nasdaq:ADAP) announced on 8/14/18 a favorable review of safety data from the second dose cohort of patients who received one billion transduced SPEAR T‑cells... read more
CEL-SCI Corporation (NYSE American: CVM) announced on 8/15/18 that the Independent Data Monitoring Committee (IDMC) for the Company's pivotal Phase 3 head and neck cancer study of its... read more
Ironshore Pharmaceuticals & Development, Inc. (“Ironshore”), a wholly owned subsidiary of Highland Therapeutics Inc., announced on 8/14/18 that it has entered into agreements with purchasers... read more
IschemaView... read more
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,